mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for REM2
Gene summary
Basic gene Info.Gene symbolREM2
Gene nameRAS (RAD and GEM)-like GTP binding 2
Synonyms-
CytomapUCSC genome browser: 14q11.2
Type of geneprotein-coding
RefGenesNM_173527.2,
DescriptionGTP-binding protein REM 2Rad and Gem-related 2 (rat homolog)rad and Gem-like GTP-binding protein 2
Modification date20141207
dbXrefs HGNC : HGNC
Ensembl : ENSG00000139890
HPRD : 08248
Vega : OTTHUMG00000170277
ProteinUniProt: Q8IYK8
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_REM2
BioGPS: 161253
PathwayNCI Pathway Interaction Database: REM2
KEGG: REM2
REACTOME: REM2
Pathway Commons: REM2
ContextiHOP: REM2
ligand binding site mutation search in PubMed: REM2
UCL Cancer Institute: REM2
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for REM2
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
A261H263YCOAD1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for REM2
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
A261H263Y-0.36284128
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for REM2 from PDB

Top
Differential gene expression and gene-gene network for REM2
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of REM2 and the right PPI network was created from samples without mutations in the LBS of REM2. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for REM2
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for REM2
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of REM2 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
GDPGUANOSINE-5'-DIPHOSPHATE3cbqAA261


Top
Conservation information for LBS of REM2
Multiple alignments for Q8IYK8 in multiple species
LBSAA sequence# speciesSpecies
A260HIETSAALHHN3Homo sapiens, Mus musculus, Rattus norvegicus
A261IETSAALHHNT3Homo sapiens, Mus musculus, Rattus norvegicus
D232VGNKSDLARSR3Homo sapiens, Mus musculus, Rattus norvegicus
G124LVGESGVGKST2Homo sapiens, Mus musculus
G124LLGESGVGKST1Rattus norvegicus
G126GESGVGKSTLA3Homo sapiens, Mus musculus, Rattus norvegicus
K127ESGVGKSTLAG3Homo sapiens, Mus musculus, Rattus norvegicus
K230ILVGNKSDLAR3Homo sapiens, Mus musculus, Rattus norvegicus
L233GNKSDLARSRE3Homo sapiens, Mus musculus, Rattus norvegicus
N229VILVGNKSDLA3Homo sapiens, Mus musculus, Rattus norvegicus
S128SGVGKSTLAGT3Homo sapiens, Mus musculus, Rattus norvegicus
S259KHIETSAALHH3Homo sapiens, Mus musculus, Rattus norvegicus
T129GVGKSTLAGTF3Homo sapiens, Mus musculus, Rattus norvegicus
V125VGESGVGKSTL2Homo sapiens, Mus musculus
V125LGESGVGKSTL1Rattus norvegicus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas